Cite
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
MLA
Wieczorek, Lindsay, et al. “Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C Gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.” Journal of Virology, vol. 89, no. 15, Aug. 2015, pp. 7478–93. EBSCOhost, https://doi.org/10.1128/JVI.00412-15.
APA
Wieczorek, L., Krebs, S. J., Kalyanaraman, V., Whitney, S., Tovanabutra, S., Moscoso, C. G., Sanders-Buell, E., Williams, C., Slike, B., Molnar, S., Dussupt, V., Alam, S. M., Chenine, A.-L., Tina Tong, Hill, E. L., Hua-Xin Liao, Hoelscher, M., Maboko, L., Zolla-Pazner, S., & Haynes, B. F. (2015). Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research. Journal of Virology, 89(15), 7478–7493. https://doi.org/10.1128/JVI.00412-15
Chicago
Wieczorek, Lindsay, Shelly J. Krebs, Vaniambadi Kalyanaraman, Stephen Whitney, Sodsai Tovanabutra, Carlos G. Moscoso, Eric Sanders-Buell, et al. 2015. “Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C Gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.” Journal of Virology 89 (15): 7478–93. doi:10.1128/JVI.00412-15.